26 results
8-K
EX-99.1
NPCE
NeuroPace Inc
8 Jan 24
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates
7:05am
.”
The NAUTILUS pivotal trial is designed to evaluate the safety and effectiveness of the RNS System as a potential treatment option for patients 12 years
S-3
EX-1.2
d5mkq11z6rxi8r9
8 Nov 22
Shelf registration
4:27pm
DEF 14A
5kg0rf6am6 bgpxh8
22 Apr 22
Definitive proxy
4:31pm
10-K
42yck
10 Mar 22
Annual report
5:19pm
10-Q
4l00i55h gpwv4mhzz
3 Jun 21
Quarterly report
4:41pm
424B4
z8h124wjdb3gj9hbkeeo
23 Apr 21
Prospectus supplement with pricing info
6:02am
POS AM
ci51sx eoptfhlwm4g5
21 Apr 21
Prospectus update (post-effective amendment)
6:06am